{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:44:02Z","timestamp":1770223442543,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12917-017-1000-0","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T04:05:04Z","timestamp":1491537904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy"],"prefix":"10.1186","volume":"13","author":[{"given":"Rowena M. A.","family":"Packer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"De Risio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger A.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,7]]},"reference":[{"key":"1000_CR1","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","volume":"45","author":"A Gaitatzis","year":"2004","unstructured":"Gaitatzis A, Carroll K, Majeed A, Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:1613\u201322.","journal-title":"Epilepsia"},{"key":"1000_CR2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.yebeh.2003.07.002","volume":"4","author":"A Boro","year":"2003","unstructured":"Boro A, Haut S. Medical comorbidities in the treatment of epilepsy. Epilepsy Behav. 2003;4:S2\u2013S12.","journal-title":"Epilepsy Behav"},{"key":"1000_CR3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1528-1167.2006.00612.x","volume":"47","author":"R Kobau","year":"2006","unstructured":"Kobau R, Gilliam F, Thurman D. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 health styles Surve Y. Epilepsia. 2006;47:1915\u201321.","journal-title":"Epilepsia"},{"issue":"12","key":"1000_CR4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/vr.103360","volume":"177","author":"RMA Packer","year":"2015","unstructured":"Packer RMA, Volk HA. Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs. Vet Rec. 2015;177(12):306\u201315.","journal-title":"Vet Rec"},{"key":"1000_CR5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0074-7742(08)00020-2","volume":"83","author":"W LaFrance Jr","year":"2008","unstructured":"LaFrance Jr W, Kanner A, Hermann B. Psychiatric comorbidities in epilepsy. Int Rev Neurobiol. 2008;83:347\u201383.","journal-title":"Int Rev Neurobiol"},{"key":"1000_CR6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.yebeh.2009.05.007","volume":"15","author":"N Seminario","year":"2009","unstructured":"Seminario N, Farias S, Jorgensen J, Bourgeois J, Seyal M. Determination of prevalence of depression in an epilepsy clinic using a brief DSM-IV-based self-report questionnaire. Epilepsy Behav. 2009;15:362\u20136.","journal-title":"Epilepsy Behav"},{"key":"1000_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/jnp.17.1.20","volume":"17","author":"C Prueter","year":"2005","unstructured":"Prueter C, Norra C. Mood disorders and their treatment in patients with epilepsy. J Neuropsychiatry Clin Neurosci. 2005;17:20\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1000_CR8","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.yebeh.2004.06.011","volume":"5","author":"D Dunn","year":"1999","unstructured":"Dunn D, Austin J. Differential diagnosis and treatment of psychiatric disorders in children and adolescents with epilepsy. Epilepsy Behav. 1999;5:S10\u20137.","journal-title":"Epilepsy Behav"},{"issue":"0 4","key":"1000_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/epi.12298","volume":"54","author":"AR Brooks-Kayal","year":"2013","unstructured":"Brooks-Kayal AR, Bath KG, Berg AT, Galanopoulou AS, Holmes GL, Jensen FE, Kanner AM, O\u2019Brien TJ, Whittemore VH, Winawer MR, et al. Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia. 2013;54(0 4):44\u201360.","journal-title":"Epilepsia"},{"issue":"5","key":"1000_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.0013-9580.2004.47003.x","volume":"45","author":"EK Johnson","year":"2004","unstructured":"Johnson EK, Jones JE, Seidenberg M, Hermann BP. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia. 2004;45(5):544\u201350.","journal-title":"Epilepsia"},{"issue":"2","key":"1000_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yebeh.2011.03.018","volume":"21","author":"N Shihab","year":"2011","unstructured":"Shihab N, Bowen J, Volk HA. Behavioral changes in dogs associated with the development of idiopathic epilepsy. Epilepsy Behav. 2011;21(2):160\u20137.","journal-title":"Epilepsy Behav"},{"issue":"3","key":"1000_CR12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/jvim.12599","volume":"29","author":"L De Risio","year":"2015","unstructured":"De Risio L, Newton R, Freeman J, Shea A. Idiopathic epilepsy in the Italian Spinone in the United Kingdom: prevalence, clinical characteristics, and predictors of survival and seizure remission. J Vet Intern Med. 2015;29(3):917\u201324.","journal-title":"J Vet Intern Med"},{"key":"1000_CR13","volume-title":"BSAVA small animal formulary 8th edition","author":"I Ramsey","year":"2014","unstructured":"Ramsey I. BSAVA small animal formulary 8th edition. Gloucester: BSAVA Small Animal Veterinary Association; 2014."},{"key":"1000_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/jvp.12117","volume":"37","author":"C Rundfeldt","year":"2014","unstructured":"Rundfeldt C, Gasparic A, Wlaz P. Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs. J Vet Pharmacol Ther. 2014;37:421\u201334.","journal-title":"J Vet Pharmacol Ther"},{"key":"1000_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1358\/dof.1998.023.03.450427","volume":"23","author":"A Rostock","year":"1998","unstructured":"Rostock A, Tober C, Dost R, Rundtfeldt C, Bartsch R, Egerland U, Stark B, Schupke H, Kronbach T, Lankau HJ, et al. AWD 131-138. Drugs Future. 1998;23:253\u20135.","journal-title":"Drugs Future"},{"key":"1000_CR16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.0013-9580.2004.21204.x","volume":"45","author":"W L\u00f6scher","year":"2004","unstructured":"L\u00f6scher W, Potschka H, Rieck S, Tipold A, Rundfeldt C. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures. Epilepsia. 2004;45:1228\u201339.","journal-title":"Epilepsia"},{"issue":"1","key":"1000_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tvjl.2005.04.003","volume":"172","author":"S Rieck","year":"2006","unstructured":"Rieck S, Rundfeldt C, Tipold A. Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot study. Vet J. 2006;172(1):86\u201395.","journal-title":"Vet J"},{"issue":"1","key":"1000_CR18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12917-015-0548-9","volume":"11","author":"C Rundfeldt","year":"2015","unstructured":"Rundfeldt C, Tipold A, L\u00f6scher W. Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up. BMC Vet Res. 2015;11(1):228.","journal-title":"BMC Vet Res"},{"key":"1000_CR19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jvp.12151","volume":"38","author":"A Tipold","year":"2015","unstructured":"Tipold A, Keefe T, L\u00f6scher W, Rundfeldt C, de Vries F. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs. J Vet Pharmacol Ther. 2015;38:160\u20138.","journal-title":"J Vet Pharmacol Ther."},{"key":"1000_CR20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12917-014-0257-9","volume":"10","author":"M Charalambous","year":"2014","unstructured":"Charalambous M, Brodbelt D, Volk H. Treatment in canine epilepsy--a systematic review. BMC Vet Res. 2014;10:257.","journal-title":"BMC Vet Res"},{"key":"1000_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40263-013-0129-z","volume":"28","author":"C Rundfeldt","year":"2014","unstructured":"Rundfeldt C, L\u00f6scher W. The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy. CNS Drugs. 2014;28:29\u201343.","journal-title":"CNS Drugs"},{"key":"1000_CR22","first-page":"458","volume":"56","author":"K Heinecke","year":"2001","unstructured":"Heinecke K. Thiel W. Identity and physicochemical properties of 1-(4-chlorophenyl)-4-morpholinoimidazolin- 2-one, AWD 131\u2013138. Pharmazie. 2001;56:458\u201361.","journal-title":"Pharmazie."},{"key":"1000_CR23","volume-title":"Manual of clinical behavioral medicine for dogs and cats","author":"KM Overall","year":"2013","unstructured":"Overall KM. Manual of clinical behavioral medicine for dogs and cats. St Louis: Elsevier Health Sciences; 2013."},{"issue":"9","key":"1000_CR24","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2460\/javma.233.9.1420","volume":"233","author":"ME Herron","year":"2008","unstructured":"Herron ME, Shofer FS, Reisner IR. Retrospective evaluation of the effects of diazepam in dogs with anxiety-related behavior problems. J Am Vet Med Assoc. 2008;233(9):1420\u20134.","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"1000_CR25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12917-015-0462-1","volume":"11","author":"L De Risio","year":"2015","unstructured":"De Risio L, Bhatti S, Munana K, Penderis J, Stein V, Tipold A, Berendt M, Farqhuar R, Fischer A, Long S, et al. International veterinary epilepsy task force consensus proposal: diagnostic approach to epilepsy in dogs. BMC Vet Res. 2015;11(1):148.","journal-title":"BMC Vet Res"},{"issue":"1","key":"1000_CR26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12917-015-0461-2","volume":"11","author":"M Berendt","year":"2015","unstructured":"Berendt M, Farquhar R, Mandigers P, Pakozdy A, Bhatti S, De Risio L, Fischer A, Long S, Matiasek K, Munana K, et al. International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals. BMC Vet Res. 2015;11(1):182.","journal-title":"BMC Vet Res"},{"issue":"9","key":"1000_CR27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2460\/javma.2003.223.1293","volume":"223","author":"Y Hsu","year":"2003","unstructured":"Hsu Y, Serpell JA. Development and validation of a questionnaire for measuring behavior and temperament traits in pet dogs. J Am Vet Med Assoc. 2003;223(9):1293\u2013300.","journal-title":"J Am Vet Med Assoc"},{"key":"1000_CR28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tvjl.2012.05.018","volume":"194","author":"L Rutherford","year":"2012","unstructured":"Rutherford L, Wessmann A, Rusbridge C, Mcgonnell IM, Abeyesinghe S, Burn CC, Volk HA. Questionnaire-based behaviour analysis of cavalier king Charles spaniels with neuropathic pain due to Chiari-like malformation and syringomyelia. Vet J. 2012;194:294\u20138.","journal-title":"Vet J"},{"key":"1000_CR29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yebeh.2015.11.014","volume":"55","author":"R Packer","year":"2016","unstructured":"Packer R, Law T, Davies E, Zhangi B, Pan Y, Volk H. Effects of a ketogenic diet on ADHD-like behaviour in dogs with idiopathic epilepsy. Epilepsy & Behavior. 2016;55:62\u20138.","journal-title":"Epilepsy & Behavior."},{"key":"1000_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12917-016-0703-y","volume":"12","author":"M Charalambous","year":"2016","unstructured":"Charalambous M, Shivapour SK, Brodbelt D, Volk HA. Antiepileptic drugs\u2019 tolerability and safety \u2013 a systematic review and meta-analysis of adverse effects in dogs. BMC Vet Res. 2016;12:79.","journal-title":"BMC Vet Res."},{"key":"1000_CR31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/vr.103736","volume":"178","author":"EJ Suiter","year":"2016","unstructured":"Suiter EJ, RMA P, Volk HA. Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy. Vet Rec. 2016;178:652.","journal-title":"Vet Rec"},{"issue":"1","key":"1000_CR32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12917-017-0957-z","volume":"13","author":"J Ne\u00dfler","year":"2017","unstructured":"Ne\u00dfler J, Rundfeldt C, L\u00f6scher W, Kostic D, Keefe T, Tipold A. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy. BMC Vet Res. 2017;13(1):33.","journal-title":"BMC Vet Res"},{"key":"1000_CR33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tvjl.2017.01.002","volume":"220","author":"E Royaux","year":"2017","unstructured":"Royaux E, Van Ham L, Broeckx BJG, Van Soens I, Gielen I, Deforce D, Bhatti SFM. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin. Vet J. 2017;220:51\u20134.","journal-title":"Vet J"},{"key":"1000_CR34","volume-title":"Behavior problems of the dog and cat","author":"G Landsberg","year":"2012","unstructured":"Landsberg G, Hunthausen W, Ackerman L. Behavior problems of the dog and cat. 3rd ed. Philadelphia: Elsevier Health Sciences; 2012.","edition":"3"},{"key":"1000_CR35","volume-title":"28th ESVN-ECVN Congress: 2015; Amsterdam","author":"O Engel","year":"2015","unstructured":"Engel O, Mueller J, FD V. Imepitoin is well tolerated by healthy cats. In: 28th ESVN-ECVN Congress: 2015; Amsterdam; 2015."},{"key":"1000_CR36","unstructured":"Dub\u00e9 MB: The use of the drug Pexion\u00ae (Imepitoin) in a cat with night-time vocalisation. In: AWSELVA-ECAWBM-ESVCE Congress: 2015; Bristol, UK; 2015."},{"key":"1000_CR37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40263-013-0129-z","volume":"28","author":"C Rundfeldt","year":"2013","unstructured":"Rundfeldt C, L\u00f6scher W. The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy. CNS Drugs. 2013;28:29\u201343.","journal-title":"CNS Drugs."},{"issue":"1","key":"1000_CR38","first-page":"35","volume":"358","author":"A Rostock","year":"1998","unstructured":"Rostock A, Tober C, Dost R, Bartsch R. AWD 131-138 is a potential novel anxiolytic without sedation and amnesia: a comparison with diazepam and buspirone. Naunyn Schmiedeberg's Arch Pharmacol. 1998;358(1):35.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"6","key":"1000_CR39","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/jm0509400","volume":"49","author":"C Grunwald","year":"2006","unstructured":"Grunwald C, Rundfeldt C, Lankau H-J, Arnold T, H\u00f6fgen N, Dost R, Egerland U, Hofmann H-J, Unverferth K. Synthesis, pharmacology, and structure\u2212activity relationships of novel Imidazolones and Pyrrolones as modulators of GABAA receptors. J Med Chem. 2006;49(6):1855\u201366.","journal-title":"J Med Chem"},{"key":"1000_CR40","doi-asserted-by":"crossref","unstructured":"Dost R, Langen B, Rundfeldt C: The a-3 subunit selective benzodiazepine agonist ELB139 does not induce tolerance in animal models for anxiety and epilepsy. Soc Neurosci Abstr 2005, 678(1).","DOI":"10.1055\/s-2005-918664"},{"key":"1000_CR41","volume-title":"Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor","author":"B Langen","year":"2005","unstructured":"Langen B, Rundfeldt C, Dost R, L\u00fcddens H, Rabe H: Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor. 2005."},{"issue":"4","key":"1000_CR42","first-page":"98","volume":"357","author":"C Tober","year":"1998","unstructured":"Tober C, Rostock A, Bartsch R. Anticonvulsant profile of AWD 131-138 a derivative of a series of imidazolinones. Naunyn Schmiedebergs Archiv Pharmacology. 1998;357(4):98.","journal-title":"Naunyn Schmiedebergs Archiv Pharmacology"},{"issue":"3","key":"1000_CR43","first-page":"97","volume":"359","author":"C Tober","year":"1999","unstructured":"Tober C, Rostock A, White HS, Wolf HH, Bartsch R. Anticonvulsant activity of AWD 131-138 in genetic animal models of epilepsy. Naunyn Schmiedebergs Archiv Pharmacology. 1999;359(3):97.","journal-title":"Naunyn Schmiedebergs Archiv Pharmacology"},{"issue":"1","key":"1000_CR44","first-page":"35","volume":"358","author":"C Tober","year":"1998","unstructured":"Tober C, Rostock A, Bartsch R. AWD 131-138: a derivative of a series of imidazolinones with anticonvulsant activity. Naunyn Schmiedeberg's Arch Pharmacol. 1998;358(1):35.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1000_CR45","volume-title":"Patent application: method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor (WO 2005\/004867 A2)","author":"B Langen","year":"2005","unstructured":"Langen B, Rundfeldt C, Dost R, L\u00fcddens H, Rabe H. Patent application: method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor (WO 2005\/004867 A2). 2005. Available at: https:\/\/www.google.ch\/patents\/US20080114032 ."},{"issue":"3\u20134","key":"1000_CR46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.applanim.2009.06.009","volume":"120","author":"G Tami","year":"2009","unstructured":"Tami G, Gallagher A. Description of the behaviour of domestic dog (Canis familiaris) by experienced and inexperienced people. Appl Anim Behav Sci. 2009;120(3\u20134):159\u201369.","journal-title":"Appl Anim Behav Sci"},{"issue":"4","key":"1000_CR47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2752\/089279399787000075","volume":"12","author":"Z Bahlig-Pieren","year":"1999","unstructured":"Bahlig-Pieren Z, Turner DC. Anthropomorphic interpretations and ethological descriptions of dog and cat behavior by lay people. Anthrozo\u00f6s. 1999;12(4):205\u201310.","journal-title":"Anthrozo\u00f6s"},{"key":"1000_CR48","volume-title":"28th ESVN-ECVN Congress: 2015; Amsterdam","author":"A Gallucci","year":"2015","unstructured":"Gallucci A, Gagliardo T, Menchetti M, Ruffini A, Bianchi E, Milici A, Tosolini P, Cauduro A, Gandini G. Efficacy of imepitoin as first choice drug in the treatment of 53 na\u00efve dogs affected by idiopathic epilepsy. In: 28th ESVN-ECVN Congress: 2015; Amsterdam; 2015."},{"issue":"8","key":"1000_CR49","doi-asserted-by":"crossref","first-page":"e106026","DOI":"10.1371\/journal.pone.0106026","volume":"9","author":"RMA Packer","year":"2014","unstructured":"Packer RMA, Shihab NK, Torres BBJ, Volk HA. Clinical risk factors associated with anti-epileptic drug responsiveness in canine epilepsy. PLoS One. 2014;9(8):e106026.","journal-title":"PLoS One"},{"key":"1000_CR50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/vr.102934","volume":"176","author":"RMA Packer","year":"2015","unstructured":"Packer RMA, Shihab NK, BBJ T, Volk HA. Responses to successive anti-epileptic drugs in canine idiopathic epilepsy. Vet Rec. 2015;176:203.","journal-title":"Vet Rec"},{"key":"1000_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/vr.103355","volume":"179","author":"A Wessmann","year":"2016","unstructured":"Wessmann A, Volk HA, Packer RMA, Ortega M, Anderson TJ. Quality-of-life aspects in idiopathic epilepsy in dogs. Vet Rec. 2016;179:229.","journal-title":"Vet Rec"},{"key":"1000_CR52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jveb.2011.05.025","volume":"7","author":"M Kato","year":"2012","unstructured":"Kato M, Miyajo K, Ohtani N, Ohta M. Effects of prescription diet on dealing with stressful situations and performance of anxiety-related behaviours in privately owned anxious dogs. J Vet Behav Clin Appl Res. 2012;7:21\u20136.","journal-title":"J Vet Behav Clin Appl Res"},{"issue":"4","key":"1000_CR53","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.jveb.2013.04.009","volume":"8","author":"S Cannas","year":"2013","unstructured":"Cannas S, Scagli E, Maltese F, Michelazzi M. Evaluation of a diet supplement on anxiety signs on dog. J Vet Behav Clin Appl Res. 2013;8(4):e29.","journal-title":"J Vet Behav Clin Appl Res"},{"key":"1000_CR54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yebeh.2015.11.014","volume":"55","author":"RMA Packer","year":"2016","unstructured":"Packer RMA, Law TH, Davies E, Zanghi B, Pan Y, Volk HA. Effects of a ketogenic diet on ADHD-like behavior in dogs with idiopathic epilepsy. Epilepsy Behav. 2016;55:62\u20138.","journal-title":"Epilepsy Behav"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-017-1000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T15:24:36Z","timestamp":1568993076000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-017-1000-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1186\/s12917-017-1000-0","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,7]]},"article-number":"90"}}